One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care
NCT ID: NCT06853626
Last Updated: 2025-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
2500 participants
INTERVENTIONAL
2025-06-27
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In acute MI events, cardiac troponins are released into the bloodstream from the damaged myocardium, where low values are used to exclude MI. Until recently, such testing has necessitated using high-sensitivity cardiac troponin (hs-cTn) assays, which have been limited to hospital laboratories. However, recent technological advancements in point-of-care (POC) testing allow access to whole-blood assays that meet high-sensitivity criteria.
In this upcoming project, the investigators will evaluate the implementation of a whole-blood POC assay (QuidelOrtho TriageTrue hs-cTnI) across six Norwegian emergency primary care clinics. The study plans to enrol 2,500 patients over a period of 1.5 years. The clinical performance of the novel strategy will be investigated, as well as its impact on healthcare utilization and hospital referrals compared to standard care. Additionally, the investigators will assess the prevalence of persistent chest pain and its effects on quality of life, alongside psychological stress and anxiety, through validated questionnaires.
This project aims to offer better and more comprehensive management of the large group of emergency primary care patients with acute chest pain, contributing to reduced hospital referrals, improved quality of life, and more sustainable use of healthcare services.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Point-of-Care Troponin Testing in the Emergency Department
NCT06845826
Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department
NCT06899776
A Study of Population and Sex-specific Troponin Cutoffs for Ruling Out Acute Myocardial Infarction
NCT05336435
Comparison of Troponin Assay With New POCT Method in the Decision-making Pathway of Patient With Chest Pain Suspected of Acute Myocardial Ischemia in Emergency Room (POCT)
NCT05764655
Troponin POCT in the Diagnosis of an Acute Myocardial Infarction
NCT03400553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
A control group will be identified to estimate the effect of the OUT-POC protocol. We will benefit from registry data to 1) estimate hospital referrals before the intervention in the same regions and 2) establish an external control group consisting of municipalities that are not using POC hs-cTn testing.
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TriageTrue hs-cTnI 0/1-hour algorithm
Study participants will have a venous blood sample done for hs-cTnI testing using the QuidelOrthos TriageTrue whole-blood POC assay. The treating physician will evaluate the results using an assay-specific 0/1-hour algorithm (developed by Boeddinghaus et al., 2020).
QuidelOrthos TriageTrue hs-cTnI whole-blood assay
Already described
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QuidelOrthos TriageTrue hs-cTnI whole-blood assay
Already described
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Troponin testing requested by the treating physician
Exclusion Criteria
* Haemodynamically unstable (direct hospital referral required)
* Not able to provide written, informed consent (i.e., due to time restraints, language barriers, impaired cognitive function, or other reasons)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Health Association
OTHER
Oslo University Hospital
OTHER
QuidelOrtho
INDUSTRY
Vestre Viken Hospital Trust
OTHER
The Dam Foundation
OTHER
Amsterdam UMC
OTHER
Sørlandet Hospital
UNKNOWN
University of Oslo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tonje R. Johannessen
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lyngen Emergency Primary Care Centre
Lyngseidet, Lyngen, Norway
Alta Emergency Primary Care Centre
Alta, , Norway
Drammen Emergency Primary Care Centre
Drammen, , Norway
Fredrikstad and Hvaler Emergency Primary Care Centre
Fredrikstad, , Norway
Oslo Accident and Emergency Outpatient Clinic
Oslo, , Norway
Trondheim Intermunicipal Emergency Primary Care Centre
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Bent Håkan Lindberg, MD, PhD
Role: primary
Anne H. Davidsen, MD, PhD student
Role: primary
Marthe H. Prytz, MD
Role: primary
Simon Andrup, MD, PhD student
Role: primary
Bjarne Austad, MD, PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Johannessen TR, Vallersnes OM, Larstorp ACK, Halvorsen S, Atar D. One-Hour Troponin Using a High-Sensitivity Point-of-Care Assay in Emergency Primary Care: The OUT-POC Pilot Study. Cardiology. 2025 Mar 7:1-13. doi: 10.1159/000545127. Online ahead of print.
Johannessen TR, Vallersnes OM, Larstorp ACK, Halvorsen S, Atar D. Authors' Response Letter - Expanding the Use of Point-of-Care hs-cTnI in Emergency Primary Care: Insights from the OUT-POC Pilot Study. Cardiology. 2025 May 22:1-3. doi: 10.1159/000546344. Online ahead of print. No abstract available.
Related Links
Access external resources that provide additional context or updates about the study.
OUT-POC pilot study
OUT-POC pilot study; Authors' Response Letter
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SDAM_FOR555568
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.